Anti–Programmed Cell Death 1/Ligand 1 (PD-1/PD-L1) Antibodies for the Treatment of Urothelial Carcinoma: State of the Art and Future Development
- Resource Type
- Review Article
- Source
- In
Clinical Genitourinary Cancer April 2018 16(2):117-129 - Subject
- Language
- ISSN
- 1558-7673